trending Market Intelligence /marketintelligence/en/news-insights/trending/b89ORDxFhwSLkh9OE5E3BA2 content esgSubNav
In This List

Orchard Therapeutics completes $110M financing, appoints director

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Orchard Therapeutics completes $110M financing, appoints director

Orchard Therapeutics Ltd completed an oversubscribed $110 million series B financing.

The company said Baillie Gifford and ORI Capital co-led the financing.

In connection with the financing, Simone Song, senior partner at ORI Capital, was appointed to Orchard's board of directors.

Orchard said it plans to use the proceeds to move its pipeline forward, including the launch of its gene therapy OTL-101.